Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16519
Abstract: Patients with sickle cell disease (SCD) are at increased risk for neurocognitive impairments. While diseaseâmodifying treatment, such as hydroxycarbamide (hydroxyurea), may decrease this risk, it has not been systematically investigated in children with SCD. We… read more here.
Keywords: thalassaemia; hydroxycarbamide; hbs thalassaemia; hbsc hbs ... See more keywords